Author

Baldo Oliva

UPF - Cited by 5,968 - protein structure - homology modeling - protein interactions - protein-DNA interactions

Biography

Dr. Baldo Oliva is an Associate professor in the Department of Clinical Experiment, Pompeu Fabra University, Spain. His study interests major on Research design, Ethical issues in humans. Currently, Dr. Baldo Oliva is the author/editors/reviewer in several international journals. He published 10 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and …
L Artigas, M Coma, P Matos-Filipe, J Aguirre-Plans, J Farrés, R Valls, ...PLoS One 15 (10), e0240149, 2020202
57
2020
Arginine citrullination at the C-terminal domain controls RNA polymerase II transcription
P Sharma, A Lioutas, N Fernandez-Fuentes, J Quilez, ...Molecular cell 73 (1), 84-96. e7, 2019201
55
2019
The exonuclease Xrn1 activates transcription and translation of mRNAs encoding membrane proteins
B Blasco-Moreno, L de Campos-Mata, R Böttcher, J García-Martínez, ...Nature communications 10 (1), 1298, 2019201
43
2019
Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
A Tapia-Abellán, D Angosto-Bazarra, C Alarcón-Vila, MC Baños, ...Science advances 7 (), eabf4468, 2021202
38
2021
In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan
G Jorba, J Aguirre-Plans, V Junet, C Segú-Vergés, JL Ruiz, A Pujol, ...PLoS One 15 (2), e0228926, 2020202
36
2020
GUILDify v2. 0: A tool to identify molecular networks underlying human diseases, their comorbidities and their druggable targets
J Aguirre-Plans, J Piñero, F Sanz, LI Furlong, N Fernandez-Fuentes, ...Journal of molecular biology 431 (13), 2477-2484, 2019201
27
2019
Find and cut-and-transfer (FiCAT) mammalian genome engineering
M Pallarès-Masmitjà, D Ivančić, J Mir-Pedrol, J Jaraba-Wallace, T Tagliani, ...Nature Communications 12 (1), 7071, 2021202
14
2021
Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
E Carcereny, A Fernández-Nistal, A López, C Montoto, A Naves, ...Oncotarget 12 (4), 316, 2021202
14
2021
An ensemble learning approach for modeling the systems biology of drug-induced injury
J Aguirre-Plans, J Piñero, T Souza, G Callegaro, SJ Kunnen, F Sanz, ...Biology Direct 16, 1-14, 2021202
13
2021
Comparative analysis of mammal genomes unveils key genomic variability for human life span
X Farré, R Molina, F Barteri, PRHJ Timmers, PK Joshi, B Oliva, S Acosta, ...Molecular Biology and Evolution 38 (11), 4948-4961, 2021202
13
2021
Understanding allergic multimorbidity within the non-eosinophilic interactome
D Aguilar, N Lemonnier, GH Koppelman, E Melén, B Oliva, M Pinart, ...PLoS One 14 (11), e0224448, 2019201
12
2019
Using collections of structural models to predict changes of binding affinity caused by mutations in protein–protein interactions
A Meseguer, L Dominguez, PM Bota, J Aguirre‐Plans, J Bonet, ...Protein Science 29 (), 2112-2130, 2020202
10
2020
Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate
JR Gutiérrez-Casares, J Quintero, G Jorba, V Junet, V Martínez, ...Frontiers in Psychiatry 12, 741170, 2021202
9
2021
First Description of Late‐Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism
D Ionescu, A Peñín‐Franch, A Mensa‐Vilaró, P Castillo, ...Arthritis & Rheumatology 74 (4), 692-699, 2022202
8
2022
Galaxy InteractoMIX: an integrated computational platform for the study of protein–protein interaction data
P Mirela-Bota, J Aguirre-Plans, A Meseguer, C Galletti, J Segura, ...Journal of molecular biology 433 (11), 166656, 2021202
8
2021
Evaluation of computationally designed peptides against TWEAK, a cytokine of the tumour necrosis factor ligand family
M Badia-Villanueva, S Defaus, R Foj, D Andreu, B Oliva, A Sierra, ...International Journal of Molecular Sciences 22 (3), 1066, 2021202
7
2021
Alternative interaction sites in the influenza A virus nucleoprotein mediate viral escape from the importin‐α7 mediated nuclear import pathway
Alternative interaction sites in the influenza A virus nucleoprotein mediate viral escape from the importin‐α mediated nuclear import pathwayP Resa‐Infante, J Bonet, S Thiele, M Alawi, S Stanelle‐Bertram, B Tuku, ...The FEBS journal 286 (1), 334-3388, 2019201
7
2019
A collection of designed peptides to target SARS-Cov-2 – ACE2 interaction: PepI-Covid19 database
R Molina, B Oliva, N Fernandez-FuentesbioRxiv, 2020.04. 28.051789, 2020202
6
2020
SPServer: split-statistical potentials for the analysis of protein structures and protein–protein interactions
J Aguirre-Plans, A Meseguer, R Molina-Fernandez, MA Marín-López, ...BMC bioinformatics 22, 1-13, 2021202
6
2021
Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis
N Mestre-Farras, S Guerrero, N Bley, E Rivero, O Coll, E Borras, E Sabido, ...Nucleic Acids Research 0 (14), 8207-822, 2022202
5
2022

Referred From: https://scholar.google.com/citations?user=IPmLGrEAAAAJ&hl=ca

Cited by
Citations 5968
h-index 41
i10-index 119
Open Access Journals